Tech Company Financing Transactions

Avitide Funding Round

Avitide secured a Series E venture capital round on 6/22/2017. Backers included Sands Capital Management, Borealis Ventures and Mithril Capital Management.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

16 Cavendish Ct.
Lebanon, NH 03766
USA

Phone

(603) 965-2100

Website

www.avitide.com

Email Address

[email protected]

Overview

Avitide develops customized biopharmaceutical affinity purification products with an industry-leading discovery and development service time.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Tillman Gerngross

        

Chief Executive Officer

Kevin Isett

        

Chief Financial Officer

Scott Kennedy

        

Chief Scientific Officer

Warren Kett

        

VP - Bus. Development

Daniel Freymeyer

        

VP - Engineering

Karol Lacki

        

VP - General Counsel

Kimberly Cornwell

        

VP - Manufacturing

Grant Espie

        

Browse more venture capital transactions:

Prev: 6/22/2017: FloQast venture capital transaction
Next: 6/22/2017: TrueLayer venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary